The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American headache society position paper

Randolph Evans, Stewart J. Tepper, Robert E. Shapiro, Christina Sun-Edelstein, Gretchen E. Tietjen

Research output: Contribution to journal › Review article › peer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American headache society position paper'. Together they form a unique fingerprint.

Medicine & Life Sciences